{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:16:03Z","timestamp":1791180963678,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.surg.2008.03.024","type":"journal-article","created":{"date-parts":[[2008,6,6]],"date-time":"2008-06-06T08:12:59Z","timestamp":1212739979000},"page":"57-65","source":"Crossref","is-referenced-by-count":52,"title":["Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2"],"prefix":"10.1016","volume":"144","author":[{"given":"Eliane","family":"Angst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard A.","family":"Reber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar J.","family":"Hines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Eibl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2008.03.024_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/08820130600754994","article-title":"Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention","volume":"35","author":"Bronte","year":"2006","journal-title":"Immunol Invest"},{"key":"10.1016\/j.surg.2008.03.024_bib2","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1158\/1535-7163.MCT-06-0686","article-title":"Tumor-stroma interactions in pancreatic ductal adenocarcinoma","volume":"6","author":"Mahadevan","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.surg.2008.03.024_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.surg.2008.03.024_bib4","first-page":"83","article-title":"Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome","volume":"152","author":"Bellocq","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.surg.2008.03.024_bib5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/jcp.2003.014498","article-title":"Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma","volume":"57","author":"Esposito","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.surg.2008.03.024_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.1999.tb09520.x","article-title":"Typing of leukocytes in pancreatic tissue surrounding human pancreatic carcinoma","volume":"880","author":"Emmrich","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.surg.2008.03.024_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrd1342","article-title":"Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention","volume":"3","author":"Braddock","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.surg.2008.03.024_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0167-4889(02)00320-8","article-title":"Summary and comparison of the signaling mechanisms of the Toll\/interleukin-1 receptor family","volume":"1592","author":"Martin","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.surg.2008.03.024_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10555-006-9004-4","article-title":"The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions","volume":"25","author":"Apte","year":"2006","journal-title":"Cancer Metastasis Rev"},{"issue":"Suppl 27","key":"10.1016\/j.surg.2008.03.024_bib10","first-page":"S1","article-title":"The IL-1 family and inflammatory diseases","volume":"20","author":"Dinarello","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.surg.2008.03.024_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2004.047100","article-title":"Prostaglandins and cancer","volume":"55","author":"Wang","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.surg.2008.03.024_bib12","first-page":"709","article-title":"Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemotherapy","volume":"12","author":"Nagai","year":"2003","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.surg.2008.03.024_bib13","first-page":"2723","article-title":"Cyclooxygenase-2 gene induction causes CDDP resistance in colon cancer cell line, HCT-15","volume":"24","author":"Saikawa","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/j.surg.2008.03.024_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1582-4934.2003.tb00222.x","article-title":"Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis","volume":"7","author":"Trifan","year":"2003","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.surg.2008.03.024_bib15","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/sj.onc.1209981","article-title":"Cyclooxygenase inhibitors modulate the p53\/HDM2 pathway and enhance chemotherapy-induced apoptosis in neuroblastoma","volume":"26","author":"Lau","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.surg.2008.03.024_bib16","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1210\/jc.2005-1362","article-title":"Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism","volume":"90","author":"Zatelli","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2008.03.024_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1097-0142(20010115)91:2<333::AID-CNCR1006>3.0.CO;2-N","article-title":"Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors","volume":"91","author":"Kokawa","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2008.03.024_bib18","first-page":"987","article-title":"Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer","volume":"59","author":"Tucker","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2008.03.024_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jcp.2005.026831","article-title":"Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer","volume":"59","author":"Juuti","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.surg.2008.03.024_bib20","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1158\/0008-5472.982.65.3","article-title":"Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor","volume":"65","author":"Eibl","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2008.03.024_bib21","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1158\/0008-5472.CAN-07-0970","article-title":"Delayed progression of pancreatic intraepithelial neoplasia in a conditional Kras(G12D) mouse model by a selective cyclooxygenase-2 inhibitor","volume":"67","author":"Funahashi","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2008.03.024_bib22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00428-003-0784-4","article-title":"A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform","volume":"442","author":"Sipos","year":"2003","journal-title":"Virchows Arch"},{"key":"10.1016\/j.surg.2008.03.024_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4049\/jimmunol.125.1.6","article-title":"Characterization of a human macrophage-like cell line stimulated in vitro: a model of macrophage functions","volume":"125","author":"Larrick","year":"1980","journal-title":"J Immunol"},{"key":"10.1016\/j.surg.2008.03.024_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bbaexp.2007.01.012","article-title":"Promoter analysis of human CC chemokine CCL23 gene in U937 monocytoid cells","volume":"1769","author":"Shin","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.surg.2008.03.024_bib25","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0006-291X(03)01079-9","article-title":"PGE(2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells","volume":"306","author":"Eibl","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.surg.2008.03.024_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1023\/B:CLIN.0000046131.24625.54","article-title":"Nerve growth factor stimulates MMP-2 expression and activity and increases invasion by human pancreatic cancer cells","volume":"21","author":"Okada","year":"2004","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.surg.2008.03.024_bib27","doi-asserted-by":"crossref","first-page":"11536","DOI":"10.1158\/0008-5472.CAN-05-2843","article-title":"The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling","volume":"65","author":"Sawai","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2008.03.024_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1097-2765(03)00053-4","article-title":"Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members","volume":"11","author":"Janssens","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.surg.2008.03.024_bib29","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.biocel.2006.03.021","article-title":"Signalling networks regulating cyclooxygenase-2","volume":"38","author":"Tsatsanis","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.surg.2008.03.024_bib30","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1038\/sj.onc.1209423","article-title":"Acquired chemoresistance in pancreatic carcinoma cells: induced secretion of IL-1beta and NO lead to inactivation of caspases","volume":"25","author":"Muerkoster","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.surg.2008.03.024_bib31","first-page":"5016","article-title":"Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I","volume":"49","author":"Covey","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2008.03.024_bib32","first-page":"80","article-title":"Efficacy of camptothecin analog DX-8951f (Exatecan Mesylate) on human pancreatic cancer in an orthotopic metastatic model","volume":"63","author":"Sun","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2008.03.024_bib33","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1200\/JCO.2006.07.0201","article-title":"Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer","volume":"24","author":"Abou-Alfa","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2008.03.024_bib34","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjc.6603301","article-title":"A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer","volume":"95","author":"Stathopoulos","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.surg.2008.03.024_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00006676-200301000-00010","article-title":"Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer","volume":"26","author":"Buchler","year":"2003","journal-title":"Pancreas"},{"key":"10.1016\/j.surg.2008.03.024_bib36","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/ijc.22332","article-title":"In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer","volume":"120","author":"Banerjee","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.surg.2008.03.024_bib37","doi-asserted-by":"crossref","first-page":"10553","DOI":"10.1158\/0008-5472.CAN-06-2333","article-title":"Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB","volume":"66","author":"El-Rayes","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2008.03.024_bib38","doi-asserted-by":"crossref","first-page":"9064","DOI":"10.1158\/0008-5472.CAN-05-1330","article-title":"Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer","volume":"65","author":"Banerjee","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2008.03.024_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/09629359990397","article-title":"Time dependent production of cytokines and eicosanoids by human monocytic leukaemia U937 cells; effects of glucocorticosteroids","volume":"8","author":"Garrelds","year":"1999","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.surg.2008.03.024_bib40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/sj.bjp.0703557","article-title":"Induction of COX-2 and PGE(2) biosynthesis by IL-1beta is mediated by PKC and mitogen-activated protein kinases in murine astrocytes","volume":"131","author":"Molina-Holgado","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.surg.2008.03.024_bib41","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1440-1746.2001.02593.x","article-title":"Interleukin-1beta induces cyclo-oxygenase-2 expression in gastric cancer cells by the p38 and p44\/42 mitogen-activated protein kinase signaling pathways","volume":"16","author":"Fan","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.surg.2008.03.024_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1440-1843.2006.00779.x","article-title":"Involvement of PKC, p38 MAPK and AP-2 in IL-1beta-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells","volume":"11","author":"Chen","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.surg.2008.03.024_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bcp.2006.09.018","article-title":"Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells","volume":"73","author":"Chen","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.surg.2008.03.024_bib44","doi-asserted-by":"crossref","first-page":"23509","DOI":"10.1074\/jbc.M003186200","article-title":"The recruitment of the interleukin-1 (IL-1) receptor-associated kinase (IRAK) into focal adhesion complexes is required for IL-1beta -induced ERK activation","volume":"275","author":"MacGillivray","year":"2000","journal-title":"J Biol Chem"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606008002171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606008002171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:37:32Z","timestamp":1684435052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606008002171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0039606008002171"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2008.03.024","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}